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Abstract 
Achalasia is a rare idiopathic, primary esophageal motility disorder. Pharmacologic, endoscopic and surgical methods are 
used in its treatment. The efficiency of the treatment is generally based on clinical “subjective” criteria. Manometry, which is the gold 
standard in diagnostic and in treatment monitoring is not always available, it is costly and it needs expertise. The role of timed barium 
esophagogram in the evaluation of the patients before and after endoscopic dilation will be discussed in the article. This method is 
standardized, less costly, and has a good correlation with clinical and manometrical results. 
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Achalasia is the most commonly seen and the best-
known primary esophageal motility disorder. This rare, 
idiopathic disorder is characterized by a failure of 
relaxation of the lower esophageal sphincter (LES) and by 
lack of peristaltic contraction of the esophageal body. In 
primary or idiopathic achalasia the failure of the deglutitive 
inhibition is responsible for aperistaltism. This dysfunction 
is caused by loss of inhibitory nerves and progressive 
degeneration of ganglion cells containing vasoactive 
intestinal peptide (VIP) and nitric oxide (NO). 
Hypertensive LES is thought to result from a combination 
of the lack of tonic inhibitory nitrergic influence and an 
unopposed cholinergic activity [1]. 
Manometry is the gold standard for the diagnosis, 
but it is available only in expert centers, so typical clinical 
and radiological manifestations may be sufficient. Barium 
swallow has long been used to diagnose achalasia. The 
classic radiological finding associated with achalasia is 
the “bird’s beak” appearance of the distal esophagus. 
Other radiological findings include an air-fluid level or a 
tortuous, sigmoid esophagus (especially in long-standing 
achalasia) [1]. 
Current treatments include pharmacologic, 
instrumental and surgical methods but none restores the 
peristalsis of the esophageal body or the normal pressure 
of the lower esophageal sphincter. Medical therapy has a 
limited and transitory effect and it is used only as a bridge 
to endoscopy or surgery. The European attitude favors 
endoscopic methods whilst surgery is preferred in the US 
[2]. 
Both endoscopic (pneumatic dilation and botulinum 
toxin injection) and surgical methods have as end points 
the relief of symptoms and the achievement of 
esophageal emptying [1, 2]. 
The success rate of the Rigiflex pneumatic 
dilatations vary from 50% to 93% [2]. This variability was 
attributed to differences in technique, although the data in 
the literature is conflicting. The decision to stop therapy is 
usually based on symptomatic relief. This “clinical 
approach” assumes that symptomatic improvement is 
associated with physiologic improvement, which is not 
always the case. Eckardt and co-workers compared a 
detailed score of clinical symptoms before and after 
treatment and observed that symptomatic improvement 
may not accurately reflect optimal or complete 
esophageal emptying [1, 3] (See Table 1). 
 
 
 
Table 1: Criteria of treatment efficiency in achalasia [1] 
Clinical   Eckardt  score < 3  
Radiology   Esophageal diameter < 3cm 
Barium column height < 1cm, 5 minutes after ingestion  
Diameter of esogastric junction of 8 to 10mm 
Manometry  Pressure of LES < 10mmHg 
 
The timed barium esophagogram (TBE) was firstly 
used by Oliveira and co-workers in 23 achalasia patients 
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studied retrospectively before and after pneumatic 
dilatation or Clostridium botulinum toxin injection [4]. The 
method is a further development of the barium 
swallowing, introducing functional and dynamic 
dimensions to the classic radiological assessment. In their 
original paper, the authors stated that their purpose was 
“to define a simple, noninvasive, and widely available 
barium technique that could serve as an objective 
measure of esophageal baseline and post-therapy 
emptying in achalasia patients”.  
The original technique described by Oliveira was to 
obtain upright frontal spot films of the esophagus at 1, 2 
and 5 minutes after the ingestion of 100-200 ml of low-
density (45% weight in volume) barium sulfate (volume of 
barium determined by patient tolerance). The authors 
concluded that timed barium swallowing is a simple and 
reproducible technique and that both qualitative 
assessment and estimated change in an area based on 
height-times-width measurements of the barium column 
are accurate methods of estimating esophageal emptying 
[4]. 
After the initial description, the method (or its 
variants) was used in treated and non-treated achalasia 
patients.  Some advantages of the TBE are: it is a 
diagnostic modality that could be used outside the tertiary 
centers, or when manometry is not available [5]. In our 
opinion, this is an excellent diagnostic tool, which offers 
acceptable accuracy and it is largely available. In addition, 
it can be utilized before the use of more advanced and 
more costly technology [5]. 
Two studies by Vaezi and coll. discuss the 
predictive value of the esophageal emptying on TBE 
before and after treatment of achalasia patients.  
In the first study [6], there was a 73% concordance 
between the degree of symptom improvement and degree 
of esophageal emptying by barium esophagogram 
(results of 53 pneumatic dilatations in 37 achalasia 
patients). The patients reporting only a slight symptom 
improvement (<50%) usually showed (17/19 patients, 
89%) a poor esophageal emptying on TBE. The study 
also showed that up to 30% of dilated patients still had 
poor esophageal emptying of barium (<50%) although 
they reported 90–100% symptom improvement [6]. The 
detractors of the TBE find a weakness of the method, 
although, in fact, this is not a pitfall but a quality.  
Starting from the hypothesis that the group of 
patients with poor esophageal emptying would have an 
earlier relapse of their symptoms when followed on long 
term, the same team conducted a new study [7]. A 
comparison between the patients with poor esophageal 
emptying (discordant group) and the patients whose 
symptom resolution correlated with marked improvement 
in esophageal emptying (concordant group) was realized. 
The primary end-point was to determine if the timed 
barium esophagogram is a better predictor of long-term 
treatment success (mean follow-up of 6 years) after 
therapy, than symptom assessment alone. The results 
confirmed the predictive value of the TBE emptying: 77% 
of the patients from the concordant group were still in 
symptomatic remission while none of the discordant group 
achieved long-term remission. In fact, (90%) patients with 
discordant findings failed therapy within one year of 
pneumatic dilations while the failure rate was constantly 
and slowly decreasing over time for the concordant group. 
Furthermore, patients in the concordant group, available 
for follow-up, continued to have complete esophageal 
emptying as well as long-term symptomatic remission [7].  
In the light of the original and follow-up studies, the 
TBE can be considered a predictor of a poor long-term 
outcome if patients continue to have post pneumatic 
dilation barium retention. Based on the TBE results a 
closer follow-up and a more aggressive further therapy 
might be offered to these patients in order to ensure long-
term remission. A new dilatation during the same 
hospitalization, a more flexible and aggressive dilatations 
program or surgery referral based on TBE is a very 
feasible approach [5]. 
Is there any real weakness of the technique? In a 
recent study from Sweden, which shows good results for 
the static parameters of the TBE (precise and 
reproducible); the esophageal emptying (dynamic) was 
considered inaccurate for the evaluation due to poor 
reproducibility [8]. Possibly these more pessimistic results 
are related to the great heterogeneity of the group of 21 
patients: 16 had a previously diagnosed achalasia and 
five had a newly established diagnosis; in nine patients 
one or two balloon dilatations were previously made and 
seven have suffered a Heller myotomy. The authors 
propose a further evaluation of the TBE in the pre- and 
post-operative evaluation of newly diagnosed achalasia 
patients who will subsequently be randomized to either 
surgery or endoscopic pneumatic dilatation [8]. 
On the other hand, a good correlation between post 
therapy reduction in LOS pressure and barium column 
height was shown in achalasia patients undergoing 
pneumatic dilation by the same team of Vaezi and al [9], 
so this is another argument for the use of TBE in the 
patient’s response to therapy evaluation.  
Esophageal manometry is probably the best 
technique for the evaluation of the response after 
pneumatic dilation but due to the cost and lack of 
availability in many centers, post-procedure manometry is 
not offered to all patients. The post-dilatation evaluation is 
not done by manometry not even in rich centers in 
Europe; we have examples in which manometry is done 
the next morning after procedure or centers where the 
result is appreciated a month after the procedure by 
radiology (especially in the US where the costs are 
somehow differently judged). 
The development of a method that could objectively 
evaluate the therapy results seemed natural and the 
results of the TBE are convincing and reliable. Its routine 
use will simplify the diagnosis, the treatment evaluation 
and the follow-up of achalasia patients. 
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